ReviewInflammatory bowel diseases2018

Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?

Ross John Porter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.